SC

SILVERARC CAPITAL MANAGEMENT, LLC

13F
SILVERARC CAPITAL MANAGEMENT, LLC
Last update 2024-08-14 69 Stocks (12 new)
Value $423.00 Mil Turnover 37 %
Countries:
Top Holdings: MRUS(8.73%)NUVL(8.35%)RNA(5.00%)URGN(4.37%)ERAS(4.36%)
Portfolio Report
Summary Stock Picks Current Portfolio
SILVERARC CAPITAL MANAGEMENT, ... Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MRUS 		Merus NV
623,628
36900.070
+10.13%
8.730
+0.80%
0.910
+3.36%
+88.18%
3542.995
Biotechnology
NUVL 		Nuvalent Inc
465,710
35328.760
+195.22%
8.350
+5.52%
0.720
+28.12%
+24.89%
6484.030
Biotechnology
RNA 		Avidity Biosciences Inc
517,734
21149.430
+5.81%
5.000
+0.27%
0.470
+6.85%
+398.23%
5330.513
Biotechnology
URGN 		UroGen Pharma Ltd
1,102,000
18491.560
+116.68%
4.370
+2.35%
2.680
-20.20%
-18.60%
514.213
Biotechnology
ERAS 		Erasca Inc
7,816,926
18447.950
+3,392.12%
4.360
+4.24%
2.770
+15.52%
+38.03%
830.563
Biotechnology
INSM CALL 		Insmed Inc
250,000
16750.000
0%
3.960
0%
0.150
-2.65%
+123.62%
12397.959
Biotechnology
MORF 		Morphic Holding Inc
486,306
16568.450
+0.48%
3.920
+0.02%
0.970
+88.50%
+97.32%
2862.305
Biotechnology
AKRO 		Akero Therapeutics Inc
625,087
14664.540
+56.29%
3.470
+1.25%
0.900
+37.56%
+40.21%
2273.163
Biotechnology
CLDX 		Celldex Therapeutics Inc
374,910
13875.420
+25.26%
3.280
+0.66%
0.570
-22.28%
-35.88%
1685.694
Biotechnology
ITCI 		Intra-Cellular Therapies Inc
192,345
13173.710
+452.60%
3.120
+2.56%
0.180
+14.70%
+24.60%
9460.966
Drug Manufacturers

SILVERARC CAPITAL MANAGEMENT, LLC's Historical Top Holdings Breakdowns

SILVERARC CAPITAL MANAGEMENT, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
NUVL 		Nuvalent Inc2024-06-30Add
+5.52%
●
62.76 ($71.13) 81.61
$91.91
29.21%
Add 195.22%
465,710
307,960
ERAS 		Erasca Inc2024-06-30Add
+4.24%
●
1.79 ($2.16) 2.63
$2.94
36.11%
Add 3392.12%
7,816,926
7,593,081
SLDB 		Solid Biosciences Inc2024-06-30Reduce
-3.15%
●
5.67 ($8.96) 12.52
$5.94
-33.71%
Reduce -64.3%
472,995
-852,070
ITCI 		Intra-Cellular Therapies Inc2024-06-30Add
+2.56%
●
64.76 ($69.36) 79.84
$89.24
28.66%
Add 452.6%
192,345
157,538
URGN 		UroGen Pharma Ltd2024-06-30Add
+2.35%
●
12.72 ($14.22) 19.2
$12.21
-14.14%
Add 116.68%
1,102,000
593,413
ALPN Alpine Immune Sciences Inc2024-06-30Sold Out
-2.19%
●
34.91 ($58.97) 64.97
$64.97
10.17%
Sold Out
0
-199,020
PRAX 		Praxis Precision Medicines Inc2024-06-30Reduce
-2.09%
●
36.55 ($47.26) 58.6
$72.73
53.89%
Reduce -64.68%
67,296
-123,260
ALNY 		Alnylam Pharmaceuticals Inc2024-06-30New Buy
+2.07%
●
143.31 ($157.87) 247
$265.29
68.04%
New holding
36,000
36,000
CATX 		Perspective Therapeutics Inc2024-06-30Reduce
-1.82%
●
9.51 ($14.46) 18.4
$12.34
-14.66%
Reduce -67.93%
260,009
-550,802
SNDX 		Syndax Pharmaceuticals Inc2024-06-30New Buy
+1.80%
●
18.82 ($20.93) 23.79
$19.69
-5.92%
New holding
370,000
370,000

SILVERARC CAPITAL MANAGEMENT, LLC Total Holding History ($B)

To

SILVERARC CAPITAL MANAGEMENT, LLC's Asset Allocation

To

SILVERARC CAPITAL MANAGEMENT, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

SILVERARC CAPITAL MANAGEMENT, LLC's Hypothetical Growth since 2024-06-30

SILVERARC CAPITAL MANAGEMENT, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

SILVERARC CAPITAL MANAGEMENT, LLC's Holdings Heat Map

Size field:

SILVERARC CAPITAL MANAGEMENT, LLC's Holdings Bubble Chart

SILVERARC CAPITAL MANAGEMENT, LLC News

  • 1

Discussions on SILVERARC CAPITAL MANAGEMENT, LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.